PUREOTCMiscellaneous Chemical ProductsFiscal year ends July 31

PURE BIOSCIENCE, INC.

Financials through Q3 FY2026, quarter ended Apr 30, 2026Last filing: 10-Q on Jun 15, 2026

$0.07−0.01 (-12.10%)

Close on Oct 19, 2026

Community

Notes and questions about Pure Bioscience from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Pure Bioscience's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-8 reverse split on Aug 15, 2012
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PURE.

Revenue growth26.8% · median 11.4%

Gross margin58.9% · median 40.0%

Operating margin-79.2% · median -343.6%

Net margin-91.2% · median -227.3%

Advertisement
300 × 250